Europe Exosome Diagnostic and Therapeutic Market Size, Share & Industry Trends Analysis Report By Application (Diagnostic and Therapeutic), By Product (Reagent, Instrument, and Software), By End User, By Country and Growth Forecast, 2022 - 2028

The Europe Exosome Diagnostic and Therapeutic Market would witness market growth of 26.2% CAGR during the forecast period (2022-2028).

Exosomes are nanovesicles that are part of an intercellular communication system. Their features appear potential as a biomarker in cancer research, which urgently requires more sophisticated monitoring and therapeutic applications. Overall survival in the case of head and neck squamous cell carcinoma (HNSCC) is generally poor, despite significant technological advances in the treatment of this illness. Diagnostic and therapeutic qualities are highlighted and summarized in the following review. Although the initial results are promising, additional research is needed before these revolutionary procedures can be implemented into daily clinical practice.

Exosomes had been widely dismissed as a form of cellular trash and had been forgotten for decades. When their capabilities for intercellular communication, involvement with the immune system, and potential use as a drug vector were discovered, everything changed. The precise definition of exosomes has sparked a lot of debate to date.

In Europe, cardiovascular diseases (CVD) continue to be the primary cause of death, accounting for 45 percent of all deaths. Every year, more than 4 million Europeans die from cardiovascular disease (CVD), primarily from CHD and stroke. Many more are admitted to hospitals, and many more acquire long-term disabilities that necessitate lifetime therapy. CVD has huge economic ramifications for Europe, in addition to human misery. CVD is predicted to cost the EU economy €210 billion per year, which includes direct health-care expenditures as well as non-health costs such as lost productivity and informal care for people with CVD. The cardiovascular disease mortality rate in Central and Eastern Europe is the highest in the world.

The Germany market dominated the Europe Exosome Diagnostic and Therapeutic Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $96.9 million by 2028. The UK market is estimated to grow at a CAGR of 25.2% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 27.2% during (2022 - 2028).

Based on Application, the market is segmented into Diagnostic and Therapeutic. Based on Product, the market is segmented into Reagent, Instrument, and Software. Based on End User, the market is segmented into Cancer Institute, Hospital, Diagnostic Center, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global Exosome Diagnostic and Therapeutic Market will Hit $1.4 Billion by 2028, at a CAGR of 26.5%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Qiagen N.V., Thermo Fisher Scientific, Inc., Aethlon Medical, Inc., Capricor Therapeutics, Inc., Malvern Panalytical Ltd., NanoSomix, Inc., System Biosciences, LLC, and NX Pharmagen, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Application

• Diagnostic
• Therapeutic

By Product

• Reagent
• Instrument
• Software

By End User

• Cancer Institute
• Hospital
• Diagnostic Center
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Bio-Techne Corporation
• Qiagen N.V.
• Thermo Fisher Scientific, Inc.
• Aethlon Medical, Inc.
• Capricor Therapeutics, Inc.
• Malvern Panalytical Ltd.
• NanoSomix, Inc.
• System Biosciences, LLC
• NX Pharmagen, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Exosome Diagnostic and Therapeutic Market, by Application
1.4.2 Europe Exosome Diagnostic and Therapeutic Market, by Product
1.4.3 Europe Exosome Diagnostic and Therapeutic Market, by End User
1.4.4 Europe Exosome Diagnostic and Therapeutic Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Exosome Diagnostic and Therapeutic Market

Chapter 4. Europe Exosome Diagnostic and Therapeutic Market by Application
4.1 Europe Diagnostic Market by Country
4.2 Europe Therapeutic Market by Country

Chapter 5. Europe Exosome Diagnostic and Therapeutic Market by Product
5.1 Europe Reagent Market by Country
5.2 Europe Instrument Market by Country
5.3 Europe Software Market by Country

Chapter 6. Europe Exosome Diagnostic and Therapeutic Market by End User
6.1 Europe Cancer Institute Market by Country
6.2 Europe Hospital Market by Country
6.3 Europe Diagnostic Center Market by Country
6.4 Europe Others Market by Country

Chapter 7. Europe Exosome Diagnostic and Therapeutic Market by Country
7.1 Germany Exosome Diagnostic and Therapeutic Market
7.1.1 Germany Exosome Diagnostic and Therapeutic Market by Application
7.1.2 Germany Exosome Diagnostic and Therapeutic Market by Product
7.1.3 Germany Exosome Diagnostic and Therapeutic Market by End User
7.2 UK Exosome Diagnostic and Therapeutic Market`
7.2.1 UK Exosome Diagnostic and Therapeutic Market by Application
7.2.2 UK Exosome Diagnostic and Therapeutic Market by Product
7.2.3 UK Exosome Diagnostic and Therapeutic Market by End User
7.3 France Exosome Diagnostic and Therapeutic Market
7.3.1 France Exosome Diagnostic and Therapeutic Market by Application
7.3.2 France Exosome Diagnostic and Therapeutic Market by Product
7.3.3 France Exosome Diagnostic and Therapeutic Market by End User
7.4 Russia Exosome Diagnostic and Therapeutic Market
7.4.1 Russia Exosome Diagnostic and Therapeutic Market by Application
7.4.2 Russia Exosome Diagnostic and Therapeutic Market by Product
7.4.3 Russia Exosome Diagnostic and Therapeutic Market by End User
7.5 Spain Exosome Diagnostic and Therapeutic Market
7.5.1 Spain Exosome Diagnostic and Therapeutic Market by Application
7.5.2 Spain Exosome Diagnostic and Therapeutic Market by Product
7.5.3 Spain Exosome Diagnostic and Therapeutic Market by End User
7.6 Italy Exosome Diagnostic and Therapeutic Market
7.6.1 Italy Exosome Diagnostic and Therapeutic Market by Application
7.6.2 Italy Exosome Diagnostic and Therapeutic Market by Product
7.6.3 Italy Exosome Diagnostic and Therapeutic Market by End User
7.7 Rest of Europe Exosome Diagnostic and Therapeutic Market
7.7.1 Rest of Europe Exosome Diagnostic and Therapeutic Market by Application
7.7.2 Rest of Europe Exosome Diagnostic and Therapeutic Market by Product
7.7.3 Rest of Europe Exosome Diagnostic and Therapeutic Market by End User

Chapter 8. Company Profiles
8.1 Bio-Techne Corporation (Exosome Diagnostic, Inc.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.2 Qiagen N.V.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.3 Thermo Fisher Scientific, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Aethlon Medical, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Research & Development Expenses
8.5 Capricor Therapeutics, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Partnerships, Collaborations, and Agreements:
8.6 Malvern Panalytical Ltd. (Spectris plc)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.7 Nanosomix, Inc.
8.7.1 Company Overview
8.8 System Biosciences, LLC
8.8.1 Company Overview
8.9 NX Pharmagen, Inc. (NX Prenatal, Inc.)
8.9.1 Company Overview

TABLE 1 Europe Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 2 Europe Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 3 Europe Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 4 Europe Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 5 Europe Diagnostic Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Diagnostic Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 10 Europe Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 11 Europe Reagent Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Reagent Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Instrument Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Instrument Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Software Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Software Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 18 Europe Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 19 Europe Cancer Institute Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Cancer Institute Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Hospital Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Hospital Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Diagnostic Center Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Diagnostic Center Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Exosome Diagnostic and Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Exosome Diagnostic and Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 29 Germany Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 30 Germany Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 31 Germany Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 32 Germany Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 33 Germany Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 34 Germany Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 35 Germany Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 36 Germany Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 37 UK Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 38 UK Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 39 UK Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 40 UK Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 41 UK Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 42 UK Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 43 UK Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 44 UK Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 45 France Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 46 France Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 47 France Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 48 France Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 49 France Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 50 France Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 51 France Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 52 France Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 53 Russia Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 54 Russia Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 55 Russia Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 56 Russia Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 57 Russia Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 58 Russia Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 59 Russia Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 60 Russia Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 61 Spain Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 62 Spain Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 63 Spain Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 64 Spain Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 65 Spain Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 66 Spain Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 67 Spain Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 68 Spain Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 69 Italy Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 70 Italy Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 71 Italy Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 72 Italy Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 73 Italy Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 74 Italy Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 75 Italy Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 76 Italy Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 77 Rest of Europe Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 78 Rest of Europe Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 79 Rest of Europe Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 80 Rest of Europe Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 81 Rest of Europe Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 82 Rest of Europe Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 83 Rest of Europe Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 84 Rest of Europe Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 85 key information – Bio-Techne Corporation
TABLE 86 Key Information – Qiagen N.V.
TABLE 87 Key Information – Thermo Fisher Scientific, Inc.
TABLE 88 Key Information – Aethlon Medical, Inc.
TABLE 89 Key Information – Capricor Therapeutics, Inc.
TABLE 90 Key Information – Malvern Panalytical Ltd
TABLE 91 Key Information – Nanosomix, Inc.
TABLE 92 Key Information – System Biosciences, LLC
TABLE 93 Key Information – NX Pharmagen, Inc.

List of Figures
FIG 1 Methodology for the research